SCIOSCIA, GIULIA
 Distribuzione geografica
Continente #
EU - Europa 2.694
NA - Nord America 2.424
AS - Asia 2.364
SA - Sud America 508
AF - Africa 35
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 2
AN - Antartide 1
Totale 8.035
Nazione #
US - Stati Uniti d'America 2.354
SG - Singapore 1.091
IE - Irlanda 828
CN - Cina 485
BR - Brasile 433
HK - Hong Kong 399
SE - Svezia 392
IT - Italia 325
RU - Federazione Russa 318
DE - Germania 213
UA - Ucraina 152
VN - Vietnam 150
FI - Finlandia 118
IN - India 71
FR - Francia 70
GB - Regno Unito 65
RO - Romania 60
CA - Canada 46
TR - Turchia 34
CZ - Repubblica Ceca 31
AR - Argentina 23
NL - Olanda 23
ES - Italia 22
BD - Bangladesh 19
IQ - Iraq 18
EC - Ecuador 16
BE - Belgio 15
ID - Indonesia 15
JP - Giappone 15
PL - Polonia 15
AT - Austria 14
MX - Messico 14
LT - Lituania 11
CO - Colombia 9
ZA - Sudafrica 9
CL - Cile 7
MY - Malesia 7
PK - Pakistan 7
PY - Paraguay 7
UZ - Uzbekistan 7
MA - Marocco 6
UY - Uruguay 6
SA - Arabia Saudita 5
TN - Tunisia 5
TW - Taiwan 5
DO - Repubblica Dominicana 4
EG - Egitto 4
IL - Israele 4
LB - Libano 4
NZ - Nuova Zelanda 4
VE - Venezuela 4
AM - Armenia 3
AU - Australia 3
BY - Bielorussia 3
HR - Croazia 3
IR - Iran 3
KE - Kenya 3
KG - Kirghizistan 3
PE - Perù 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AZ - Azerbaigian 2
DK - Danimarca 2
DZ - Algeria 2
GR - Grecia 2
JO - Giordania 2
KR - Corea 2
MK - Macedonia 2
NO - Norvegia 2
PH - Filippine 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BS - Bahamas 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
DJ - Gibuti 1
EU - Europa 1
GP - Guadalupe 1
HU - Ungheria 1
JM - Giamaica 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
ML - Mali 1
MM - Myanmar 1
NG - Nigeria 1
NP - Nepal 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 8.035
Città #
Dublin 828
Singapore 510
Chandler 401
Hong Kong 393
Ashburn 302
Nyköping 294
Beijing 181
Dallas 159
Santa Clara 123
Munich 101
Jacksonville 94
New York 77
Princeton 73
Helsinki 71
Moscow 68
Ho Chi Minh City 65
Boardman 60
Los Angeles 60
Timisoara 56
The Dalles 55
Dearborn 49
Turku 38
Frankfurt am Main 36
Foggia 34
São Paulo 32
Nanjing 31
Wilmington 31
Hanoi 27
Pune 27
Brno 25
Ann Arbor 23
Bari 21
Düsseldorf 21
Nuremberg 20
Chicago 18
Falkenstein 18
San Francisco 18
Brooklyn 17
Rio de Janeiro 17
Toronto 17
London 16
Seattle 16
Des Moines 15
Guangzhou 15
Shanghai 15
Boston 14
Brussels 14
Nanchang 14
Phoenix 12
Chengdu 11
Council Bluffs 11
Milan 11
Stockholm 11
Warsaw 11
Amsterdam 10
Tokyo 10
Belo Horizonte 9
Buffalo 9
Porto Alegre 9
Rome 9
Wuhan 9
Atlanta 8
Denver 8
Jiaxing 8
Lauterbourg 8
Montreal 8
San Mateo 8
Shenyang 8
Washington 8
Ankara 7
Charlotte 7
Cutrofiano 7
Jinan 7
Paris 7
Portsmouth 7
San Jose 7
Vienna 7
Biên Hòa 6
Curitiba 6
Florence 6
Haiphong 6
Hangzhou 6
Hải Dương 6
Johannesburg 6
Naples 6
New Delhi 6
Ribeirão Preto 6
Sorocaba 6
Tashkent 6
Asunción 5
Brasília 5
Chennai 5
Hebei 5
Jakarta 5
Kuala Lumpur 5
Noicattaro 5
Quito 5
Redwood City 5
Santo André 5
Springfield 5
Totale 4.989
Nome #
Expression profiling of miRNA-145 and miRNA-338 in serum and sputum of patients with COPD, asthma, and asthma–COPD overlap syndrome phenotype 149
Looking for airways periostin in severe asthma: could it be useful for clustering T2-high endotype? 136
Emorragia alveolare diffusa (DAH): recidiva della granulomatosi di Wegener dopo un trattato inadeguato 132
Exhaled breath condensate and respiratory diseases 111
Assessment of Induced Sputum Cellularity in COPD Patients Belonging to Two Different Classes of Air Pollution Exposure 110
Study of mitochondrial DNA alteration in the exhaled breath condensate of patients affected by obstructive lung diseases 107
A survey of fungal microbiota in airways of healthy volunteer subjects from Puglia (Apulia), Italy 107
A survey of fungal microbiota in airways of healthy volunteer subjects from Puglia (Apulia), Italy 100
Real Time PCR and Culture-Based Virus Isolation Test in Clinically Recovered Patients: Is the Subject Still Infectious for SARS-CoV2? 99
Effetti a lungo termine della terapia con omalizumab, in pazienti con asma severo persistente non controllato 98
Surgical mask and n95 in healthcare workers of covid-19 departments: Clinical and social aspects 96
Assessing value of contrast-enhanced ultrasound vs. conventional transthoracic ultrasound in improving diagnostic yield of percutaneous needle biopsy of peripheral lung lesions 93
Mortality in obstructive sleep apnea syndrome (OSAS) and overlap syndrome (OS): The role of nocturnal hypoxemia and CPAP compliance 89
MicroRNA expression profile during different conditions of hypoxia 89
A case of severe allergic eosinophilic asthma with nasal polyposis in a patient affected by birt-hogg-dubé syndrome successfully treated with benralizumab 88
Physical activity as a new tool to evaluate the response to omalizumab and mepolizumab in severe asthmatic patients: A pilot study 87
Omalizumab as add-on therapy in a patient with severe asthma and OSA 86
Disturbo bipoplare tipo II: un caso di disassuefazione tabagica e reinserimento sociale 84
Surgical mask and n95 in healthcare workers of covid-19 departments: Clinical and social aspects 83
Obstructive Sleep Apnea Worsens Progression-Free and Overall Survival in Human Metastatic Colorectal Carcinoma 83
Clinical Factors Associated with a Shorter or Longer Course of Antibiotic Treatment in Patients with Exacerbations of Bronchiectasis: A Prospective Cohort Study 80
Impact of CT Scan Phenotypes in Clinical Manifestations, Management and Outcomes of Hospitalised Patients With COVID-19 79
Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study 79
Physical activity as a new tool to evaluate the response to omalizumab and mepolizumab in severe asthmatic patients: A pilot study 78
Molecular study of the lung microbiome in patients with non-cystic fibrosis bronchiectasis: the contribution of Pseudomonas aeruginosa infection to clinical outcomes 77
Is the Exhaled Breath Temperature Sensitive to Cigarette Smoking? 77
Tabagismo e malattie fumo-correlate 77
Exhaled breath temperature in NSCLC: Could be a new non invasive marker? 76
Imaging profile after treatment with Tocilizumab in COVID-19: a case series 75
Asma bronchiale 75
Downregulation of exosomal let-7d and miR-16 in idiopathic pulmonary fibrosis 75
Impact of CT Scan Phenotypes in Clinical Manifestations, Management and Outcomes of Hospitalised Patients with COVID-19 75
The Role of Transthoracic Ultrasound in the Study of Interstitial Lung Diseases: High-Resolution Computed Tomography Versus Ultrasound Patterns: Our Preliminary Experience 74
Knowledge of telemedicine in a sleep clinic during the COVID-19 pandemic by a phone survey 73
Effectiveness of Benralizumab in Improving the Quality of Life of Severe Eosinophilic Asthmatic Patients: Our Real-Life Experience 73
Chest Imaging in the Diagnosis and Management of Pulmonary Tuberculosis: The Complementary Role of Thoraci Ultrasound 73
Low sensitivity of admission lung us compared to chest ct for diagnosis of lung involvement in a cohort of 82 patients with covid-19 pneumonia 73
Survival of patients with idiopathic pulmonary fibrosis and pulmonary hypertension under therapy with nintedanib or pirfenidone 71
Treatment response according to small airways disease status: The effects of high-strength extrafine pMDI beclomethasone dipropionate/formoterol fumarate in fixed dose combination in moderate uncontrolled asthmatic patients 71
Machine learning-based prediction of adherence to continuous positive airway pressure (CPAP) in obstructive sleep apnea (OSA) 71
Exhaled Nitric Oxide and Exhaled Breath Temperature as Potential Biomarkers in Patients with Pulmonary Hypertension 70
Exhaled Breath Temperature Home Monitoring to Detect NSCLC Relapse: Results from a Pilot Study 70
Effect of Hypoxia-Induced Micro-RNAs Expression on Oncogenesis 69
A Report on a Targeted Screening Population for Alpha-1-Antitrypsin Deficiency (AATD) in Central-Southern Italy 69
Transthoracic ultrasound sign in severe asthmatic patients: a lack of “gliding sign” mimic pneumothorax 69
The Potential Role of Airways Periostin in the Clinical Practice of Patients Affected by Idiopathic Pulmonary Fibrosis 69
How Are We Handling the Post-COVID Patients? The Dance of Uncertainties 69
Obstructive Sleep Apnoea-Hypopnoea Syndrome (OSAHS): state of the art 68
Severe uncontrolled asthma with bronchiectasis: A pilot study of an emerging phenotype that responds to mepolizumab 68
Extracellular Vesicle Surface Signatures in IPF Patients: A Multiplex Bead-Based Flow Cytometry Approach 68
Different Expression of Micro-RNA in the Subcutaneous and Visceral Adipose Tissue of Obese Subjects 67
Looking for airways periostin in severe asthma: could it be useful for clustering T2-high endotype? 67
Effectiveness of Benralizumab in Improving the Quality of Life of Severe Eosinophilic Asthmatic Patients: Our Real-Life Experience 67
Chylothorax found in a patient with COVID-19 67
Searching for Inflammatory and Oxidative Stress Markers Capable of Clustering Severe Asthma 66
Chylothorax found in a patient with COVID-19 66
Clinical and economic consequences of switching from omalizumab to mepolizumab in uncontrolled severe eosinophilic asthma 65
Lung Ultrasound in the Diagnosis of COVID-19 Pneumonia: Not Always and Not Only What Is COVID-19 “Glitters” 65
COVID-19 Pneumonia: The Great Ultrasonography Mimicker 64
Association between physical activity and risk of hospitalisation in bronchiectasis 64
Aetiological diagnosis in new adult outpatients with bronchiectasis:role of predictors derived from real life experience 63
Transthoracic ultrasound shear wave elastography for the study of subpleural lung lesions 63
Early effectiveness of type-2 severe asthma treatment with dupilumab in a real-life setting; a FeNO-driven choice that leads to winning management 62
Survival of patients with idiopathic pulmonary fibrosis and pulmonary hypertension under therapy with nintedanib or pirfenidone 62
Could transthoracic ultrasound be useful to suggest a small airways disease in severe uncontrolled asthma? 61
Early effectiveness of type-2 severe asthma treatment with dupilumab in a real-life setting; a FeNO-driven choice that leads to winning management 60
Impact of smoking, COPD and comorbidities on the mortality of COVID-19 patients 60
Efficacy of prone positioning in COVID-19 pneumonia according to radiological phenotypes 60
Exhaled Breath Temperature Home Monitoring to Detect NSCLC Relapse: Results from a Pilot Study 60
Clinical Features of SARS-COV-2 Infection After Full Vaccination in Health Care Workers of a COVID Hospital 59
The Potential Role of Airways Periostin in the Clinical Practice of Patients Affected by Idiopathic Pulmonary Fibrosis 59
The Onset of Antinuclear Antibodies (ANAs) as a Potential Risk Factor for Mortality and Morbidity in COVID-19 Patients: A Single-Center Retrospective Study 58
Extracellular Vesicle Surface Signatures in IPF Patients: A Multiplex Bead-Based Flow Cytometry Approach 58
Study of mitochondrial DNA alteration in the exhaled breath condensate of patients affected by obstructive lung diseases 58
Real-world experience with dupilumab in severe asthma: One-year data from an italian named patient program 58
The Role of Airways 17β-Estradiol as a Biomarker of Severity in Postmenopausal Asthma: A Pilot Study 56
Searching for Inflammatory and Oxidative Stress Markers Capable of Clustering Severe Asthma 56
Usefulness of sleep events detection using a wrist worn peripheral arterial tone signal device (WatchPAT™) in a population at low risk of obstructive sleep apnea 55
Transthoracic Ultrasound in Infectious Organizing Pneumonia: A Useful Guide for Percutaneous Needle Biopsy 55
A Review on Biological Effects of Ultrasounds: Key Messages for Clinicians 54
Different dyspnoea perception in COPD patients with frequent and infrequent exacerbations 52
Therapeutic effects of benralizumab assessed in patients with severe eosinophilic asthma: Real-life evaluation correlated with allergic and non-allergic phenotype expression 52
Treatment response according to small airways disease status: The effects of high-strength extrafine pMDI beclomethasone dipropionate/formoterol fumarate in fixed dose combination in moderate uncontrolled asthmatic patients 51
Usefulness of sleep events detection using a wrist worn peripheral arterial tone signal device (WatchPAT™) in a population at low risk of obstructive sleep apnea 50
Effectiveness of benralizumab in severe eosinophilic asthma: Distinct sub-phenotypes of response identified by cluster analysis 50
Soluble P-selectin in acute exacerbations and stable bronchiectasis in adults 50
Different dyspnoea perception in COPD patients with frequent and infrequent exacerbations 45
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma treated with Mepolizumab: The REMI-M study 45
EVs-miRNA: The New Molecular Markers for Chronic Respiratory Diseases 45
Breath and Sputum Analyses in Asthmatic Patients: An Overview 45
null 45
Clinical Remission in Patients Affected by Severe Eosinophilic Asthma on Dupilumab Therapy: A Long-Term Real-Life Study 44
Bayesian Integration of Bronchoalveolar Lavage miRNAs and KL-6 in Progressive Pulmonary Fibrosis Diagnosis 44
Thoracic ultrasound combined with low-dose computed tomography may represent useful screening strategy in highly exposed population in the industrial city of Taranto (Italy) 44
Utility of Clustering in Mortality Risk Stratification in Pulmonary Hypertension 44
Exhaled volatile organic compounds analysis by e-nose can detect idiopathic pulmonary fibrosis 44
Low Diagnostic Accuracy of Transthoracic Ultrasound for the Assessment of Spontaneous Pneumothorax in the Emergency Setting: A Multicentric Study 43
Adaptive immunity in different CT patterns of active tuberculosis and possible variability according to patients' geographic provenience 43
Interstitial lung diseases with concomitant lung cancer: a data mining approach revealing a complex condition with gender- and immune-associated specific implications 43
Cluster Analysis Identifies Patients With Severe Eosinophilic Asthma Who Achieve Super-Response and Remission With Mepolizumab 43
Totale 6.975
Categoria #
all - tutte 58.157
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.157


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021159 0 0 0 0 0 4 31 23 55 31 2 13
2021/2022397 25 1 4 7 45 6 22 22 57 87 4 117
2022/20232.062 157 96 105 88 123 213 11 179 976 15 41 58
2023/2024514 78 16 20 11 36 113 36 33 11 12 5 143
2024/20252.634 110 41 92 64 81 375 235 191 542 285 342 276
2025/20262.078 365 411 537 523 232 10 0 0 0 0 0 0
Totale 8.516